Published in Iran J Pharm Res on January 01, 2015
Preparation and In-vitro Evaluation of Rifampin-loaded Mesoporous Silica Nanoaggregates by an Experimental Design. Iran J Pharm Res (2015) 0.75
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev (2008) 3.80
Structure and design of polymeric surfactant-based drug delivery systems. J Control Release (2001) 3.48
Trends and developments in liposome drug delivery systems. J Pharm Sci (2001) 2.06
Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J Control Release (2005) 1.97
The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials (2009) 1.82
Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials (2010) 1.54
Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts. J Pharm Sci (2000) 1.21
Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur J Pharm Biopharm (2004) 1.18
Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials (2004) 1.15
Fabrication of porous hollow silica nanoparticles and their applications in drug release control. J Control Release (2004) 1.09
The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials (2009) 1.08
Assessment of uptake and toxicity of fluorescent silica nanoparticles in zebrafish (Danio rerio) early life stages. Aquat Toxicol (2010) 1.06
Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model. Int J Pharm (2008) 0.96
Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery. Drug Deliv (2007) 0.94
Anticancer Activity of Nanoparticles Based on PLGA and its Co-polymer: In-vitro Evaluation. Iran J Pharm Res (2013) 0.91
In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles. J Control Release (2009) 0.91
Sustained release of naproxen in a new kind delivery system of carbon nanotubes hydrogel. Iran J Pharm Res (2013) 0.90
Porous hollow silica nanoparticles as carriers for controlled delivery of ibuprofen to small intestine. J Nanosci Nanotechnol (2006) 0.89
Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa. Biomaterials (2009) 0.86
In vitro evaluation of sol-gel processed spray dried silica gel microspheres as carrier in controlled drug delivery. Int J Pharm (2000) 0.86
Drug delivery systems based on inorganic materials: I. Synthesis and characterization of a zeolite-cyclophosphamide system. J Biomater Sci Polym Ed (1994) 0.83
Preparation and In-vitro Evaluation of Rifampin-loaded Mesoporous Silica Nanoaggregates by an Experimental Design. Iran J Pharm Res (2015) 0.75